ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

BTMD vs JNJ // GROSS PROFIT MARGIN

Biote Corp. (Class A) (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: BTMD 3 — JNJ 7
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BTMD VS. JNJ) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC BTMD JNJ SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin ACTIVE — 67.90% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 85.00% 25.50% +59.50 BTMD /roic <GO>
EV/EBITDA & P/E Valuation 2.9x 18.5x -15.60 BTMD /valuation <GO>
Free Cash Flow Yield — 2.97% — TIE /fcf-yield <GO>
Operating Margin 18.50% 34.70% -16.20 JNJ /operating-margins <GO>
Net Profit Margin 14.10% 28.50% -14.40 JNJ /net-margins <GO>
Revenue Growth (YoY) -2.50% 6.00% -8.50 JNJ /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 4.11% 0.00% +4.11 BTMD /dividend-safety <GO>
Altman Z-Score & Debt/Equity 2.50 5.59 -3.09 JNJ /balance-sheet <GO>
Piotroski F-Score Quality 6/9 8/9 -2.00 JNJ /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 43.5 62.1 -18.56 JNJ /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 1.08 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 23.0x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $42.0M $662.49B -$662.45B JNJ /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR BTMD REV JNJ REV BTMD GROSS % JNJ GROSS % BTMD FCF JNJ FCF
FY 2025 $192.2M $94.19B — 67.9% $30.2M $19.70B
FY 2024 $197.2M $88.82B — 69.1% $38.8M $19.84B
FY 2023 $185.4M $85.16B — — $26.9M $18.96B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BTMD // BETA —
JNJ // BETA 1.08